# Maternal Fecal Microbiota Transplantation Mitigates Hypertension in Offspring Exposed to a High-Fructose Diet

**Authors:** Chien-Ning Hsu, Chih-Yao Hou, Hong-Tai Tzeng, Kay L. H. Wu, Wei-Chia Lee, Guo-Ping Chang-Chien, Shu-Fen Lin, You-Lin Tain

PMC · DOI: 10.3390/antiox14101168 · Antioxidants · 2025-09-25

## TL;DR

Maternal fecal transplants from healthy donors can reduce high blood pressure in offspring caused by a high-fructose diet during pregnancy.

## Contribution

This study shows maternal FMT can prevent hypertension in offspring via gut microbiota and metabolic changes.

## Key findings

- Maternal FMT reduced offspring systolic blood pressure by ~8 mmHg in high-fructose diet groups.
- FMT increased plasma butyrate and SCFA receptor expression while reducing oxidative stress markers.
- Four gut microbiota enterotypes were linked to different blood pressure outcomes in offspring.

## Abstract

Excessive maternal fructose intake contributes to the developmental programming of hypertension in offspring, partly via gut microbiota dysbiosis and oxidative stress. Fecal microbiota transplantation (FMT) may restore microbial balance and modulate short-chain fatty acid (SCFA) production. We investigated whether maternal FMT from healthy donors could prevent hypertension in offspring exposed to a high-fructose (HF) diet. Pregnant Sprague Dawley rats (n = 12) were fed normal chow (ND) or a 60% HF diet from mating to delivery. Cross-FMT was performed: HF dams received FMT from ND donors, and ND dams received FMT from HF donors. Male offspring (n = 8/group) were assigned to ND, HF, ND + HF-FMT, or HF + ND-FMT groups. Offspring of HF dams developed higher systolic blood pressure (+13 mmHg vs. ND, p < 0.05). Maternal FMT from ND donors reduced this elevation by ~8 mmHg (p < 0.05). Protective effects were accompanied by higher plasma butyrate, increased expression of SCFA receptors (GPR41, GPR43), reduced renal oxidative stress markers (8-OHdG), and distinct gut microbiota profiles. Maternal FMT generated four enterotypes in offspring, each associated with differential blood pressure outcomes. These findings suggest that maternal microbiota-targeted interventions, such as FMT, can mitigate hypertension of developmental origin by restoring gut microbial and metabolic homeostasis.

## Linked entities

- **Genes:** FFAR3 (free fatty acid receptor 3) [NCBI Gene 2865], FFAR2 (free fatty acid receptor 2) [NCBI Gene 2867]
- **Chemicals:** butyrate (PubChem CID 104775), 8-OHdG (PubChem CID 135440064)

## Full-text entities

- **Genes:** Ffar3 (free fatty acid receptor 3) [NCBI Gene 365228] {aka Gpr41}, Ffar2 (free fatty acid receptor 2) [NCBI Gene 292794] {aka Gpr43}
- **Diseases:** Hypertension (MESH:D006973)
- **Chemicals:** butyrate (MESH:D002087), SCFA (MESH:D005232), 8-OHdG (MESH:D000080242), Fructose (MESH:D005632), HF (-)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12562263/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12562263/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12562263/full.md

---
Source: https://tomesphere.com/paper/PMC12562263